Neuroscience News -
15 Jun 2019 02:06
Researchers injected a modified segment of the amyloid precursor protein into mouse models of Alzheimer's disease. The treatment appeared to reverse a number of the cognitive and memory problems associated with the neurodegenerative disease.
Share this Article
Comment on this Article
Please to comment